EP3106149
Samsetningar til dreifingar í lungu á langverkandi múskarín-mótlyfjum og langverkandi beta-2 adrenviðtakaörvum og tengdar aðferðir og kerfi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.5.2010EP published:
20.11.2019EP application number:
16164845.6
EP translation filed:
13.2.2020Grant published:
15.3.2020EPO information:
European Patent Register
Max expiry date:
27.5.2030Expiry date:
27.5.2026Next due date:
31.5.2026
Title:
COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA-2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS
Timeline
Today
28.5.2010EP application
20.11.2019EP Publication
13.2.2020Translation submitted
15.3.2020Registration published
27.5.2026Expires
Owner
Name:
Pearl Therapeutics, Inc.Address:
200 Saginaw Drive, 94063, Redwood City, CA, US
Inventor
Name:
VEHRING, ReinhardAddress:
Redwood City, CA, US
Name:
HARTMAN, Michael, StevenAddress:
Palo Alto, CA, US
Name:
SMITH, Adrian, EdwardAddress:
Emerald Hills, CA, US
Name:
JOSHI, Vidya, BAddress:
Redwood City, CA, US
Name:
DWIVEDI, Sarvajna, KumarAddress:
Redwood City, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
182565 PDate:
29.5.2009Country:
US
Number:
258172 PDate:
4.11.2009Country:
US
Number:
309365 PDate:
1.3.2010Country:
US
Number:
345536 PDate:
17.5.2010Country:
US
Classification
Categories:
A61K 9/12, A61K 9/00, A61K 9/16, A61K 31/40, A61K 31/167, A61K 31/56, A61K 31/58, A61K 31/46, A61K 31/137, A61K 31/573, A61P 11/00, A61M 15/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 4.5.2020
Expires: 27.5.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 8.4.2021
Expires: 27.5.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.4.2022
Expires: 27.5.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 12.4.2023
Expires: 27.5.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 9.4.2024
Expires: 27.5.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 13.5.2025
Expires: 27.5.2026
Payer: Árnason Faktor ehf.